User:Katiejaneanderson/sandbox

margaret liu

Karolinska Institutet, ProTherImmune

Prophylactic & Therapeutic Immunity Providing consultant services for investment and biopharmaceutical companies evaluating prophylactic vaccine and therapeutic immunization technologies and candidates for the global community

http://www.gatesfoundation.org/Media-Center/Press-Releases/2000/10/Margaret-Lui-MD-New-Senior-Advisor (2000)

"Dr. Liu has extensive experience in vaccine development in the industrial sector with a commitment to developing products to benefit populations in developing countries," said Dr. Gordon Perkin, Director of the Global Health Program at the Bill & Melinda Gates Foundation. "She will greatly strengthen the work we do in vaccines."

Most recently, Dr. Liu was a consultant to various projects in the areas of vaccine research and gene therapy. Previously, she was Vice President of Vaccine Research and Gene Therapy at the Chiron Corporation, a biotech firm in California, and a Senior Director at Merck & Co., Inc. Dr. Liu also has served on the faculty of the Harvard Medical School.

In addition to overseeing the Foundation's vaccine work, Dr. Liu will assist the World Health Organization, the Global Fund for Children's Vaccines and other agencies with vaccine-related activities.

http://www.vaccinecongress.com/bio-liu.html

http://discovermagazine.com/2002/nov/feat50#.UxYrMUJ_vIs: Margaret A. Liu Vice Chairman, Transgene, Strasbourg, France. HIV mutates so quickly that it can outmaneuver traditional vaccines made from viral proteins or weakened viruses. Worse, a vaccine made from a weakened virus could prove deadly if the virus mutated and regained virulence. Liu's work has shown that DNA may offer "the hope of better, more stable vaccines that can be rapidly produced." DNA injected as a vaccine might signal the body to churn out proteins that protect against HIV by provoking an immune response to the virus.